Page 227 - 89Zr-Immuno-PET:Towards a Clinical Tool to Guide Antibody-based Therapy in Cancer

LIST OF PUBLICATIONS
• Jauw YWS, Bensch F, Brouwers AH, Hoekstra OS, Zijlstra JM, Pieplenbosch S, Schröder CP, Zweegman S, van Dongen GAMS, Menke-van der Houven- van Oordt CW, de Vries EGE, de Vet HCW, Boellaard R, Huisman MC. Interobserver reproducibility of tumor uptake quantification with 89Zr- immuno-PET. Eur J Nucl Med Mol Imaging. 2019 Jun 17. doi: 10.1007/ s00259-019-04377-6. [Epub ahead of print]
• Jauw YWS, O’Donoghue JA, Hoekstra OS, Menke-van der Houven van oordt CW, Morschhauser F, Carrasquillo JA, Zweegman S, Pandit-Taskar N, Lammertsma AA, van Dongen GAMS, Boellaard R, Weber WA, Huisman MC. 89Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo. J Nucl Med. 2019 May 30. pii: jnumed.118.224568. doi: 10.2967/jnumed.118.224568. [Epub ahead of print]
• Jauw YWS, Heijtel DF, Zijlstra JM, Hoekstra OS, de Vet HCW, Vugts DJ, Verheul HM, Boellaard R, Zweegman S, van Dongen GAMS, Menke-van der Houven-van Oordt CW, Lammertsma AL, Huisman MC. Noise induced variability of immuno-PET with Zirconium-89-labeled antibodies: an analysis based on count-reduced clinical images. Mol Imaging Biol. 2018 Dec;20(6):1025- 1034. doi: 10.1007/s11307-018-1200-4.
• Jauw YWS, Huisman MC, Nayak TK, Vugts DJ, Christen R, Naegelen VM, Ruettinger D, Heil F, Lammertsma AA, Verheul HMW, Hoekstra OS, van Dongen GAMS, Menke-van der Houven van Oordt CW. Assessment of target- mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody. EJNMMI Res. 2018 Jan 22;8(1):6. doi: 10.1186/s13550- 018-0358-8.
• Jauw YWS, Zijlstra JM, de Jong D, Vugts DJ, Zweegman S, Hoekstra OS, van Dongen GA, Huisman MC. Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma. PLoS One. 2017 Jan 6;12(1) e0169828. doi: 10.1371/journal.pone.0169828.
A
List of publications
A
225